A CRL is issued when the FDA decides not to approve new or generic drug application for marketing in its present form
Brought to you by Times of India. Further reading: https://ift.tt/2KN96xk
* * * * *
Business Standard, India’s leading business site for Live Markets, Live BSE & NSE quotes, latest news, breaking news, political news, analysis and opinion on markets, companies, industry, economy, policy, banking and personal finance news and more.